If your AI-generated marketing content still sounds like everyone else's, the place to start is what happens before the ...

Python stays far ahead after another dip; C holds second, Java retakes third from C++, and R rises to eighth as SQL slips, ...

Dr. Reddy's Laboratories (NVO) will launch its off-patent version of Novo Nordisk’s (NVO) blockbuster GLP-1 therapy Ozempic in Canada within the “next few days,” becoming the first to sell a generic ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The day has ...

This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...

A generic version of Wegovy is not currently available in the United States due to patents held by the manufacturer, Novo Nordisk, that may remain in effect until 2041. When the U.S. patent for ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Global ...

Apotex Inc., Canada’s largest drug maker, has won Health Canada approval to sell a generic form of the blockbuster Ozempic. The Toronto-based company is the second manufacturer to get an approval, ...

Today, Health Canada authorized a second generic semaglutide injection. Health Canada is currently reviewing seven other submissions for generic semaglutide by different companies. Today, Health ...